| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180041 Administering to or transplanting into patient at least one cell or tissue obtained from a cloned ungulate animal or embryo |
| 09/16/2004 | US20040179974 Multi-format sample processing devices, methods and systems |
| 09/16/2004 | US20040178988 Wheel motion control input device for animation system |
| 09/16/2004 | US20040177807 Electrospraying apparatus and method for coating particles |
| 09/16/2004 | DE202004006675U1 Apparatus to purify and isolate nucleic acids, for diagnosis from small samples taken from e.g. blood, has two interconnected hollow bodies with a nucleic acid bonding material at the inlet to the second body |
| 09/16/2004 | DE19958961B4 Nukleinsäuren zur Herstellung von transgenen Pflanzen mit erhöhter Phytopathogen-Resistenz Nucleic acids for the production of transgenic plants with increased resistance to phytopathogen |
| 09/16/2004 | DE19956272B4 Verfahren zur gesteuerten Nach-Ernte-Produktion von Proteinen in Wirtsorganismen Method for the controlled post-harvest production of proteins in host organisms |
| 09/16/2004 | DE10309729A1 Humane Nukleinsäuresequenzen aus Harnblasenkarzinomen Nucleic acid sequences from human bladder carcinoma |
| 09/16/2004 | DE10309169A1 Rekombinante, FAD-abhängige Sulfhydryloxidasen, Verfahren zu deren Herstellung und deren Verwendung Recombinant FAD-dependent Sulfhydryloxidasen, processes for their preparation and their use |
| 09/16/2004 | DE10119203B4 Verfahren zur Erzeugung von doppelsträngigen Nukleinsäuren mit einzelsträngigen Überhängen beliebiger Länge und Nukleotidzusammensetzung A process for the production of double stranded nucleic acids with single-stranded overhangs of arbitrary length and nucleotide composition |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2518402A1 Process for producing lactonase and utilization thereof |
| 09/16/2004 | CA2518400A1 Transgenic plants modified to accumulate fructooligosaccharides and production thereof |
| 09/16/2004 | CA2518237A1 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | CA2518150A1 Methods and compositions involving mda-7 |
| 09/16/2004 | CA2518046A1 Screening method for genes of brewing yeast |
| 09/16/2004 | CA2517974A1 Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 09/16/2004 | CA2517899A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2517879A1 Enhanced amylose production in plants |
| 09/16/2004 | CA2517857A1 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | CA2517856A1 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 09/16/2004 | CA2517767A1 Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof |
| 09/16/2004 | CA2517601A1 Infectious flavivirus pseudo-particles containing functional prm-e envelope proteins |
| 09/16/2004 | CA2517591A1 Ph dependent signaling dna enzymes |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517518A1 Streptococcus pyogenes antigens |
| 09/16/2004 | CA2517375A1 Chicken rna polymerisate i promoter and the use thereof |
| 09/16/2004 | CA2517158A1 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2517101A1 A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/16/2004 | CA2517097A1 Identification of antigen epitopes |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | CA2516519A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | CA2514730A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 09/15/2004 | EP1457571A1 Reporter gene assay method |
| 09/15/2004 | EP1457569A1 Process for the preparation of S-adenosylmethionine |
| 09/15/2004 | EP1457565A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 09/15/2004 | EP1457564A2 Production of plants having improved rooting efficiency and vase life using stress-resistance gene |
| 09/15/2004 | EP1457563A1 Regulation of quinolate phosphoribosyl transferase expression |
| 09/15/2004 | EP1457562A1 Regulation of quinolate phosphorribosyl transferase expression |
| 09/15/2004 | EP1457561A1 Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carrp) and phytoene dehydrogenase (carb) |
| 09/15/2004 | EP1457560A1 High-activity phytase compositions |
| 09/15/2004 | EP1457559A1 ARTIFICIAL ANTIBODY LIBRARY WITH SUPER−REPERTORY |
| 09/15/2004 | EP1457558A1 WEED CONTROLLER METABOLISM PROTEINS, GENES THEREOF AND USE OF THE SAME |
| 09/15/2004 | EP1457557A1 Novel proteins and dnas thereof |
| 09/15/2004 | EP1457554A1 Process for producing biodegradable polyester |
| 09/15/2004 | EP1457553A1 Plastic plate and plastic plate assembly |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1457496A1 high density immobilization of nucleic acids |
| 09/15/2004 | EP1457211A1 Recombinant vaccinia virus vaccine |
| 09/15/2004 | EP1457210A1 Remedies and/or preventives for conformational diseases |
| 09/15/2004 | EP1456669A2 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 09/15/2004 | EP1456668A2 Protein arrays for allelic variants and uses thereof |
| 09/15/2004 | EP1456663A2 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456652A2 Agents that modulate immune cell activation and methods of use thereof |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456648A2 Automated sample preparation methods and devices |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456645A2 Methods for determining the prognosis for cancer patients using tucan |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456416A2 Multiplex oligonucleotide addition and target amplification |
| 09/15/2004 | EP1456413A1 Method of detection of prostate cancer |
| 09/15/2004 | EP1456411A2 Methods of detecting modification of genetic material |
| 09/15/2004 | EP1456410A2 Method for displaying loops from immunoglobulin domains in different contexts |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456401A2 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456396A1 Hybrid glycosylated products and their production and use |
| 09/15/2004 | EP1456394A2 Methods of using improved polymerases |
| 09/15/2004 | EP1456392A2 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 09/15/2004 | EP1456391A1 Process for the preparation of l-amino acids using coryneform bacteria |
| 09/15/2004 | EP1456390A2 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 09/15/2004 | EP1456389A1 Methods and means for gene silencing in plants |
| 09/15/2004 | EP1456388A1 Genetic strain optimization for improving the production of riboflavin |
| 09/15/2004 | EP1456387A2 Expression vector for the production of annexin v |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456384A2 Novel alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456381A1 Human prostate cancer candidate protein 1 |
| 09/15/2004 | EP1456380A2 Smad7 inhibitors for the treatment of cns diseases |
| 09/15/2004 | EP1456379A2 Compositions and methods for modulating plant development |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456376A2 Novel chimeric rev, tat, and nef antigens |
| 09/15/2004 | EP1456375A1 Screening methods employing fish model assessment of vision |
| 09/15/2004 | EP1456374A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 09/15/2004 | EP1456373A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 09/15/2004 | EP1456372A2 Emission ratiometric indicators of phosphorylation |
| 09/15/2004 | EP1456370A2 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
| 09/15/2004 | EP1456369A1 Polypeptides having protease activity and nucleic acids encoding same |
| 09/15/2004 | EP1456368A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456367A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |